Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD22-specific T cell receptors and adoptive T cell therapy for treatment of B cell malignancies

CD22-specific T cell receptors and adoptive T cell therapy for treatment of B cell malignancies

US Patent 12421290 · Granted Sep 23, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD5 specific T cell receptor cell or gene therapy2025
CD5 specific T cell receptor cell or gene therapy2025
Specific t cell receptors against epitopes of mutant MYD88L265P protein for adop2025
High avidity antigen recognizing constructs2025
High avidity antigen recognizing constructs2022
High avidity HPV T-cell receptors2022
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restric2020
Tumor specific T-cell receptors2020
High avidity antigen recognizing constructs2019
Epitope-tag surface expressed proteins and nucleic acids thereof2015
Peptides regulating the surface expression of the T cell receptor2015
Use of Pol III promoters for controlled expression of therapeutic proteins2015